影响剂量学计算变异性的因素国际研究第2部分:吸收剂量的总体变异性
该国际研究基于核医学与分子影像学会177Lu剂量学挑战的5项任务,评估不同成像协议、分割、时间积分和剂量计算步骤对吸收剂量估计变异性的影响。结果显示平面成像协议(T2)的器官吸收剂量比纯SPECT/CT(T1)低约60%且差异有统计学意义,提供分割和时间积分数据后变异性降低。
要点
- 平面成像协议(T2)的器官吸收剂量比纯SPECT/CT(T1)低约60%,差异有统计学意义。
- 至少有一次SPECT/CT采集时(T1、T3、T4、T5),剂量估计的平均差异在±10%以内。
- 提供分割和时间积分数据后,吸收剂量的变异性降低。
核心结论
- 随着向参与者提供分割和时间积分数据,吸收剂量的变异性降低。
- 结果提示基于SPECT/CT的成像协议比平面成像方法产生更一致且变异性更小的结果。
- 应努力标准化分割和拟合,因为这可能大幅降低吸收剂量的变异性。
研究设计与样本
- 该研究为核医学与分子影像学会177Lu剂量学挑战的一部分,包含5项任务(T1-T5),旨在评估剂量学工作流程中成像协议、分割、时间积分和剂量计算步骤相关的剂量估计变异性。
- 研究使用了2例接受177Lu-DOTATATE治疗患者的匿名数据集,包括系列平面和定量SPECT/CT扫描、器官和病灶轮廓以及时间积分活度图,供全球参与者进行剂量学计算并提交结果。
- 数据经过仔细整理以排除形式错误和方法学错误,计算了吸收剂量的描述性统计,并使用四分位离散系数测量变异性。
主要发现
- 从平面成像协议(T2)估计的器官吸收剂量比纯SPECT/CT(T1)低约60%,差异有统计学意义。
- 当至少有一次SPECT/CT采集可用时(T1、T3、T4、T5),剂量估计的平均差异在±10%以内,且大多数器官和病灶与T1的差异无统计学意义。
- 使用系列SPECT/CT图像时,T1的器官和病灶吸收剂量四分位离散系数平均分别小于20%和26%。
- T4(提供分割)的器官和病灶吸收剂量四分位离散系数平均分别为20%和18%。
- T5(提供分割和时间积分活度图)的器官和病灶吸收剂量四分位离散系数平均分别为10%和5%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dosimetry for personalized radiopharmaceutical therapy has gained considerable attention. Many methods, tools, and workflows have been developed to estimate absorbed dose (AD). However, standardization is still required to reduce variability of AD estimates across centers. One effort for standardization is the Society of Nuclear Medicine and Molecular Imaging 177Lu Dosimetry Challenge, which comprised 5 tasks (T1-T5) designed to assess dose estimate variability associated with the imaging protocol (T1 vs. T2 vs. T3), segmentation (T1 vs. T4), time integration (T4 vs. T5), and dose calculation (T5) steps of the dosimetry workflow. The aim of this work was to assess the overall variability in AD calculations for the different tasks. Methods: Anonymized datasets consisting of serial planar and quantitative SPECT/CT scans, organ and lesion contours, and time-integrated activity maps of 2 patients treated with 177Lu-DOTATATE were made available globally for participants to perform dosimetry calculations and submit their results in standardized submission spreadsheets. The data were carefully curated for formal mistakes and methodologic errors. General descriptive statistics for ADs were calculated, and statistical analysis was performed to compare the results of different tasks. Variability in ADs was measured using the quartile coefficient of dispersion. Results: ADs to organs estimated from planar imaging protocols (T2) were lower by about 60% than those from pure SPECT/CT (T1), and the differences were statistically significant. Importantly, the average differences in dose estimates when at least 1 SPECT/CT acquisition was available (T1, T3, T4, T5) were within ±10%, and the differences with respect to T1 were not statistically significant for most organs and lesions. When serial SPECT/CT images were used, the quartile coefficients of dispersion of ADs for organs and lesions were on average less than 20% and 26%, respectively, for T1; 20% and 18%, respectively, for T4 (segmentations provided); and 10% and 5%, respectively, for T5 (segmentation and time-integrated activity images provided). Conclusion: Variability in ADs was reduced as segmentation and time-integration data were provided to participants. Our results suggest that SPECT/CT-based imaging protocols generate more consistent and less variable results than planar imaging methods. Effort at standardizing segmentation and fitting should be made, as this may substantially reduce variability in ADs.
引用
- Brosch-Lenz J, Ke S, Wang H, et al. An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 2: Overall Variabilities in Absorbed Dose. J Nucl Med. 2023. PMID: 37024302. doi:10.2967/jnumed.122.265094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。